annual EBITDA:
-$133.99M+$71.12M(+34.68%)Summary
- As of today (June 22, 2025), TXG annual EBITDA is -$133.99 million, with the most recent change of +$71.12 million (+34.68%) on December 31, 2024.
- During the last 3 years, TXG annual EBITDA has fallen by -$109.39 million (-444.78%).
- TXG annual EBITDA is now -883.40% below its all-time high of -$13.63 million, reached on December 31, 2017.
Performance
TXG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$23.69M+$14.12M(+37.35%)Summary
- As of today (June 22, 2025), TXG quarterly EBITDA is -$23.69 million, with the most recent change of +$14.12 million (+37.35%) on March 31, 2025.
- Over the past year, TXG quarterly EBITDA has increased by +$22.62 million (+48.84%).
- TXG quarterly EBITDA is now -1158.87% below its all-time high of -$1.88 million, reached on March 31, 2019.
Performance
TXG quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$111.37M+$22.62M(+16.88%)Summary
- As of today (June 22, 2025), TXG TTM EBITDA is -$111.37 million, with the most recent change of +$22.62 million (+16.88%) on March 31, 2025.
- Over the past year, TXG TTM EBITDA has increased by +$99.03 million (+47.07%).
- TXG TTM EBITDA is now -705.76% below its all-time high of -$13.82 million, reached on September 30, 2018.
Performance
TXG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TXG EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.7% | +48.8% | +47.1% |
| 3 y3 years | -444.8% | +29.5% | -107.2% |
| 5 y5 years | -541.5% | -48.8% | -218.8% |
TXG EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -444.8% | +34.7% | -203.2% | +70.5% | -107.2% | +47.1% |
| 5 y | 5-year | -541.5% | +73.9% | -824.8% | +94.1% | -352.8% | +78.3% |
| alltime | all time | -883.4% | +73.9% | -1158.9% | +94.1% | -705.8% | +78.3% |
TXG EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$23.69M(-37.3%) | -$111.37M(-16.9%) |
| Dec 2024 | -$133.99M(-34.7%) | -$37.82M(+59.7%) | -$133.99M(+2.2%) |
| Sep 2024 | - | -$23.69M(-9.5%) | -$131.06M(-30.2%) |
| Jun 2024 | - | -$26.18M(-43.5%) | -$187.69M(-10.8%) |
| Mar 2024 | - | -$46.31M(+32.7%) | -$210.40M(+2.6%) |
| Dec 2023 | -$205.11M(+59.6%) | -$34.88M(-56.6%) | -$205.11M(+15.2%) |
| Sep 2023 | - | -$80.32M(+64.3%) | -$178.04M(+37.5%) |
| Jun 2023 | - | -$48.88M(+19.2%) | -$129.52M(-4.7%) |
| Mar 2023 | - | -$41.02M(+424.9%) | -$135.92M(+5.8%) |
| Dec 2022 | -$128.49M(+422.4%) | -$7.81M(-75.4%) | -$128.49M(-0.5%) |
| Sep 2022 | - | -$31.81M(-42.5%) | -$129.13M(+21.3%) |
| Jun 2022 | - | -$55.28M(+64.6%) | -$106.47M(+98.1%) |
| Mar 2022 | - | -$33.59M(+297.4%) | -$53.76M(+118.6%) |
| Dec 2021 | -$24.59M | -$8.45M(-7.7%) | -$24.59M(-94.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$9.15M(+257.3%) | -$419.03M(-10.8%) |
| Jun 2021 | - | -$2.56M(-42.1%) | -$469.87M(-6.5%) |
| Mar 2021 | - | -$4.43M(-98.9%) | -$502.28M(-2.2%) |
| Dec 2020 | -$513.77M(+2359.7%) | -$402.89M(+571.6%) | -$513.77M(+350.4%) |
| Sep 2020 | - | -$59.99M(+71.5%) | -$114.07M(+87.2%) |
| Jun 2020 | - | -$34.97M(+119.6%) | -$60.93M(+74.4%) |
| Mar 2020 | - | -$15.92M(+399.3%) | -$34.93M(+67.2%) |
| Dec 2019 | -$20.89M(-80.3%) | -$3.19M(-53.4%) | -$20.89M(-77.2%) |
| Sep 2019 | - | -$6.85M(-23.7%) | -$91.60M(-7.1%) |
| Jun 2019 | - | -$8.97M(+376.7%) | -$98.58M(+10.0%) |
| Mar 2019 | - | -$1.88M(-97.5%) | -$89.61M(+2.1%) |
| Dec 2018 | -$106.08M(+678.6%) | -$73.90M(+434.7%) | -$87.73M(+534.7%) |
| Sep 2018 | - | -$13.82M | -$13.82M |
| Dec 2017 | -$13.63M | - | - |
FAQ
- What is 10x Genomics annual EBITDA?
- What is the all time high annual EBITDA for 10x Genomics?
- What is 10x Genomics annual EBITDA year-on-year change?
- What is 10x Genomics quarterly EBITDA?
- What is the all time high quarterly EBITDA for 10x Genomics?
- What is 10x Genomics quarterly EBITDA year-on-year change?
- What is 10x Genomics TTM EBITDA?
- What is the all time high TTM EBITDA for 10x Genomics?
- What is 10x Genomics TTM EBITDA year-on-year change?
What is 10x Genomics annual EBITDA?
The current annual EBITDA of TXG is -$133.99M
What is the all time high annual EBITDA for 10x Genomics?
10x Genomics all-time high annual EBITDA is -$13.63M
What is 10x Genomics annual EBITDA year-on-year change?
Over the past year, TXG annual EBITDA has changed by +$71.12M (+34.68%)
What is 10x Genomics quarterly EBITDA?
The current quarterly EBITDA of TXG is -$23.69M
What is the all time high quarterly EBITDA for 10x Genomics?
10x Genomics all-time high quarterly EBITDA is -$1.88M
What is 10x Genomics quarterly EBITDA year-on-year change?
Over the past year, TXG quarterly EBITDA has changed by +$22.62M (+48.84%)
What is 10x Genomics TTM EBITDA?
The current TTM EBITDA of TXG is -$111.37M
What is the all time high TTM EBITDA for 10x Genomics?
10x Genomics all-time high TTM EBITDA is -$13.82M
What is 10x Genomics TTM EBITDA year-on-year change?
Over the past year, TXG TTM EBITDA has changed by +$99.03M (+47.07%)